Feedback / Questions
CLR 125 - Cellectar
https://www.globenewswire.com/news-release/2025/06/24/3104237/29076/en/Cellectar-Biosciences-Submits-Phase-1b-Clinical-Trial-Protocol-to-US-Food-and-Drug-Administration-for-CLR-125-to-Treat-Triple-Negative-Breast-Cancer-TNBC.html
Jun 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next